Literature DB >> 8452099

Leptomeningeal toxoplasmosis after allogeneic marrow transplantation. Case report and review of the literature.

D C Seong1, D Przepiorka, J M Bruner, P Van Tassel, W K Lo, R E Champlin.   

Abstract

A 37-year-old woman with chronic myelogenous leukemia underwent allogeneic bone marrow transplantation with CD8-depleted marrow from an HLA-identical sister. On day 43 post-transplant, the patient developed a headache and became lethargic and tremulous. Magnetic resonance imaging (MRI) of the brain showed abnormal meningeal and superficial parenchymal enhancement anteriorly. The spinal fluid had an elevated protein level with normal glucose and a neutrophilic pleocytosis. At autopsy, Toxoplasma meningoencephalitis was seen. On review of the literature, headache and confusion at 1-2 months post-transplant are common presenting signs of central nervous system toxoplasmosis. The predominance of neutrophils in the spinal fluid in this patient probably reflects the meningeal component of the infection and is an unusual finding. The presentation of toxoplasmosis in marrow transplant recipients is quite pleomorphic, and a definite diagnosis is difficult to obtain antemortem. Empiric therapy with pyrimethamine and sulfadiazine should be considered for marrow transplant recipients with neurologic deficits for which there is no other apparent etiology.

Entities:  

Mesh:

Year:  1993        PMID: 8452099     DOI: 10.1097/00000421-199304000-00004

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  2 in total

1.  Unusual magnetic resonance imaging presentation of post-BMT cerebral toxoplasmosis masquerading as meningoencephalitis and ventriculitis.

Authors:  K J Helton; G Maron; E Mamcarz; V Leventaki; Z Patay; Z Sadighi
Journal:  Bone Marrow Transplant       Date:  2016-06-27       Impact factor: 5.483

2.  Toxoplasmosis after renal transplantation: implications of a missed diagnosis.

Authors:  M W H Wulf; R van Crevel; R Portier; C G Ter Meulen; W J G Melchers; A van der Ven; J M D Galama
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.